The British pharmaceutical company AstraZeneca has acknowledged that its Covid vaccine, Covishield, can lead to rare side effects like blood clots and low platelet count. The vaccine, produced by the Serum Institute of India, faces a class action lawsuit in the UK, with 51 cases seeking up to £100 million in damages. AstraZeneca’s admission contradicts its previous stance and may lead to compensation for affected individuals.
Read More at Ndtv
